GSK revenue and financials

GSK · NYSE · USD

Secondary listing. The primary listing is GSK · LSE (GBp)

$46.60Change from previous close: +0.11%Absolute change: +$0.05

Close · October 6, 2026

In the fiscal year ended December 2025, GSK reported revenue of £32.67B (+4.11% year over year). Net income was £5.72B, a net margin of 17.5%.

Annual revenue · 2025: £32.67B
  1. £27.89B2016
  2. £30.19B2017
  3. £30.82B2018
  4. £33.75B2019
  5. £24.35B2020
  6. £24.7B2021
  7. £29.32B2022
  8. £30.33B2023
  9. £31.38B2024
  10. £32.67B2025

Fiscal year ending in December. Sources and method on the page Methodology and sources.

At a glance

Revenue growth
+4.11%
2025 vs 2024
Net income growth
+121.98%
2025 vs 2024
Net margin
17.5%
2024: 8.2%

Financial data

Amounts in millions of GBP; per-share values in GBP; shares in millions.

Balance sheet · Annual
Item2025202420232022202120202019201820172016
Total assets61,11859,46359,00560,14679,10380,43179,69258,06656,38159,081
Current assets17,51016,99718,64420,76918,67420,24719,49116,92715,90716,711
Cash and equivalents3,3973,8702,9363,7234,2746,2924,7073,8743,8334,897
Short-term investments9.021.042.067.0614—————
Receivables7,3746,9357,4037,1157,478—————
Inventory5,9245,6695,4985,1465,783—————
Net property, plant and equipment10,04810,0739,9579,62010,672—————
Goodwill7,0186,9826,8117,04610,55210,59710,5625,7895,7345,965
Other intangible assets16,74815,51514,76814,31830,079—————
Long-term investments1,1261,1961,1921,5412,276—————
Current liabilities21,39121,69721,06822,81023,67022,14824,05022,49126,56919,001
Accounts payable3,5353,4623,7183,8664,535—————
Long-term debt14,45313,09515,04017,19719,83820,78025,21521,62113,17813,804
Total debt17,72016,98618,01820,987——————
Total liabilities45,16246,37746,21050,05057,76159,62361,33554,39452,89254,118
Total equity (incl. minority)15,95613,08612,79510,09621,342—————
Retained earnings10,9578,7677,7434,7928,747—————
Minority interest-421-585-552-5026,287—————